secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000885725-24-000007
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific to acquire Axonics for $71.00 per share in cash
-----------------------------------------------------------------

- Each Axonics share will be converted into $71.00 in cash, without interest.
- Termination fee of $75M payable by Axonics for superior proposal; $140M payable by Boston Scientific if antitrust fails after Axonics stockholder approval.
- Transaction subject to Axonics stockholder approval, HSR waiting period, and other regulatory consents.
- Axonics board unanimously recommends adoption of the merger agreement.
- Customary no-shop clause with fiduciary out allows Axonics to consider superior proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572524000007/0000885725-24-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572524000007/bsx-20240108.htm
  HTML page:      https://secwatch.observer/filing/0000885725-24-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer